2101 Wilson Blvd, Suite 900
From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish-skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions. We provide our customers with innovative digital tools for managing their business that include the use artificial intelligence (AI) to support insurance billing.
We have regional headquarters in the United States, Iceland, and Germany. Our 500 employees worldwide include a U.S. salesforce of more than 200 professionals.
Chester Kitt is a 70-year-old fisherman and motorcycle enthusiast from Marysville, WA. He was at risk of having his foot amputated due to a wound that wouldn’t heal. After numerous attempts to close the wound, however, a solution was finally found with Kerecis fish skin. https://www.kerecis.com/fish-skin-saves-a-fisherman-from-amputation/
47 articles about Kerecis
Kerecis® Shield™, the new fish-skin wound-treatment product family for private doctors’ clinics, has been approved by multiple leading Medicare Administrative Contractors.
Kerecis®, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, is donating its GraftGuide® fish-skin burn product for victims of the fires on Maui, Hawaii.
SAWC – Kerecis® announced MariGen® Shield, which integrates the company’s proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds.
More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment
Kerecis announced that, over the past year, 63 million more Americans became eligible for insurance coverage for the company’s fish-skin treatments, an increase of more than 70%.
Kerecis, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, announced the release of two new products for the burn market, GraftGuide Mano™ and GraftGuide Micro™.
Kerecis®, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection, has received authorization from the FDA to market Kerecis Omega3 SurgiBind™.
The easy-to-use fish-skin graft fills a void as wound-treatment companies withdraw human-derived products per FDA guidance
Kerecis®, the company that is pioneering the use of fish skin in tissue regeneration and wound care, announced its new product, Kerecis Omega3 GraftGuide™, at the 43rd Annual John A. Boswick Burn & Wound Care Symposium.
Researchers from the U.S. Army Institute of Surgical Research have found that Kerecis Omega3 Burn fish skin has better wound-healing properties than fetal bovine dermis.
Kerecis, the fastest growing company in the regenerative-tissue market in the United States, has appointed Mike Cadigan as its chief financial officer.
Company that uses fish skin to heal human wounds and damaged tissue continues its rapid growth
A Silicon Valley Bank credit facility and additional financing from other lenders increase operational flexibility and support the company’s long-term strategy
Medical Fish Skin Company Kerecis to Release a Telemedicine App, Providing Access to Personalized Wound-Treatment Product Advice
The new Kerecis telemedicine service, TeleKer™, enables healthcare providers to get timely, personalized advice on how to treat wounds with Kerecis products.
Kerecis®, the company that is pioneering the use of fish skin in tissue regeneration and wound care, will present the results of multiple studies of its technology at the Symposium on Advanced Wound Care (SAWC) Fall meeting to be held in Las Vegas, Nevada, October 12 to 14 (booth 527).
Olafur Ragnar Grimsson, who was the President of Iceland for 20 years, has joined the board of Kerecis Limited.
Kerecis Limited, the company pioneering the use of fish skin in tissue regeneration, has completed a $16 million Series C funding round.
The Icelandic Growth Consortium has named Kerecis one of the country's fastest growing companies for three consecutive years.
New Research on the Kerecis Fish-Skin-Grafts Wound Treatment to be Presented at the Symposium on Advanced Wound Care
Dr. David Armstrong and Dr. Allen Raphael (DPM) will present results of multiple studies of Kerecis' medical fish skin at the Symposium on Advanced Wound Care (SAWC) Spring meeting, May 7 to 11, in San Antonio.
Kerecis, the company pioneering the use of fish skin in tissue regeneration, announced that the President of Iceland, HE Gudni Johannesson, has awarded the company's Aurora Award to nurse Lisa Anne Jeffers and Dr. Bryan Folkers.
Kerecis to Acquire Swiss Life-Science Company Phytoceuticals, Gains Approval of Kerecis Omega3 Wound for Reimbursement in Switzerland
Kerecis, the company pioneering the use of fish skin in tissue regeneration, today received a notice from Swiss healthcare authorities that the company's lead product, Kerecis Omega3 Wound, will be reimbursed in Switzerland.